Susquehanna Fundamental Investments »

Karyopharm Therapeutics shares owned by Susquehanna Fundamental Investments

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Susquehanna Fundamental Investments from 13F filings

Historical chart of Susquehanna Fundamental Investments investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Susquehanna Fundamental Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Susquehanna Fundamental Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $227k 23k 9.77

More positions owned by Susquehanna Fundamental Investments

Ge Aerospace Com New (GE)
Visa Com Cl A (V)
Uber Technologies (UBER)
Automatic Data Processing (ADP)
Waste Management (WM)
Qualcomm (QCOM)
Chubb (CB)
Blackrock (BLK)
Microsoft Corporation (MSFT)
TransDigm Group Incorporated (TDG)
Mastercard Incorporated Cl A (MA)
Arm Holdings Sponsored Ads (ARM)
FedEx Corporation (FDX)
Trane Technologies SHS (TT)
Moody's Corporation (MCO)

View all positions for Susquehanna Fundamental Investments

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics